18F- Fluorothymidine to Evaluate Treatment Response in Lymphoma
Genetic Determinations for Side Effects and Response Rate for Patients Receiving Chemotherapy With Diffuse Large Cell Lymphoma
|3||Active, not recruiting||
Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment
† Study has passed its completion date and status has not been verified in more than two years.